Literature DB >> 9822691

Action of human group IIa secreted phospholipase A2 on cell membranes. Vesicle but not heparinoid binding determines rate of fatty acid release by exogenously added enzyme.

R S Koduri1, S F Baker, Y Snitko, S K Han, W Cho, D C Wilton, M H Gelb.   

Abstract

Human group IIa phospholipase A2 (hIIa-PLA2) is a highly basic protein that is secreted from a number of cells during inflammation and may play a role in arachidonate liberation and in destruction of invading bacteria. It has been proposed that rodent group IIa PLA2 is anchored to cell surfaces via attachment to heparan sulfate proteoglycan and that this interaction facilitates lipolysis. hIIa-PLA2 contains 13 lysines, 2 histidines, and 10 arginines that fall into 10 clusters. A panel of 26 hIIa-PLA2 mutants were prepared in which 1-4 basic residues in each cluster were changed to glutamate or aspartate (charge reversal). A detailed analysis of the affinities of these mutants for anionic vesicles and for heparin and heparan sulfate in vitro and of the specific activities of these proteins for hydrolysis of vesicles in vitro and of living cell membranes reveal the following trends: 1) the affinity of hIIa-PLA2 for heparin and heparan sulfate is modulated not by a highly localized site of basic residues but by diffuse sites that partially overlap with the interfacial binding site. In contrast, only those residues on the interfacial binding site of hIIa-PLA2 are involved in binding to membranes; 2) the relative ability of these mutants to hydrolyze cellular phospholipids when enzymes were added exogenously to CHO-K1, NIH-3T3, and RAW 264.7 cells correlates with their relative in vitro affinity for vesicles and not with their affinity for heparin and heparan sulfate. 3) The rates of exogenous hIIa-PLA2-catalyzed fatty acid release from wild type CHO-K1 cells and two mutant lines, one lacking glycosaminoglycan and one lacking heparan sulfate, were similar. Thus basic residues that modulate interfacial binding are important for plasma membrane fatty acid release by exogenously added hIIa-PLA2. Binding of hIIa-PLA2 to cell surface heparan sulfate does not modulate plasma membrane phospholipid hydrolysis by exogenously added hIIa-PLA2.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9822691     DOI: 10.1074/jbc.273.48.32142

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  The molecular basis of phosphatidylcholine preference of human group-V phospholipase A2.

Authors:  K P Kim; S K Han; M Hong; W Cho
Journal:  Biochem J       Date:  2000-06-15       Impact factor: 3.857

2.  Biochemical characterization of selective inhibitors of human group IIA secreted phospholipase A(2) and hyaluronic acid-linked inhibitor conjugates.

Authors:  Rob C Oslund; Michael H Gelb
Journal:  Biochemistry       Date:  2012-10-18       Impact factor: 3.162

3.  Phosphatidic acid mediates activation of mTORC1 through the ERK signaling pathway.

Authors:  Jeremiah N Winter; Todd E Fox; Mark Kester; Leonard S Jefferson; Scot R Kimball
Journal:  Am J Physiol Cell Physiol       Date:  2010-04-28       Impact factor: 4.249

4.  Mechanisms governing the level of susceptibility of erythrocyte membranes to secretory phospholipase A2.

Authors:  Lauren B Jensen; Nancy K Burgess; Denise D Gonda; Emily Spencer; Heather A Wilson-Ashworth; Erin Driscoll; Mai P Vu; Jeremy L Fairbourn; Allan M Judd; John D Bell
Journal:  Biophys J       Date:  2005-01-28       Impact factor: 4.033

5.  Kinetic evaluation of cell membrane hydrolysis during apoptosis by human isoforms of secretory phospholipase A2.

Authors:  Erin D Olson; Jennifer Nelson; Katalyn Griffith; Thaothanh Nguyen; Michael Streeter; Heather A Wilson-Ashworth; Michael H Gelb; Allan M Judd; John D Bell
Journal:  J Biol Chem       Date:  2010-02-05       Impact factor: 5.157

6.  Wall teichoic acid deficiency in Staphylococcus aureus confers selective resistance to mammalian group IIA phospholipase A(2) and human beta-defensin 3.

Authors:  Tomaz Koprivnjak; Christopher Weidenmaier; Andreas Peschel; Jerrold P Weiss
Journal:  Infect Immun       Date:  2008-03-17       Impact factor: 3.441

7.  Selective inhibition of human group IIA-secreted phospholipase A2 (hGIIA) signaling reveals arachidonic acid metabolism is associated with colocalization of hGIIA to vimentin in rheumatoid synoviocytes.

Authors:  Lawrence K Lee; Katherine J Bryant; Romaric Bouveret; Pei-Wen Lei; Anthony P Duff; Stephen J Harrop; Edwin P Huang; Richard P Harvey; Michael H Gelb; Peter P Gray; Paul M Curmi; Anne M Cunningham; W Bret Church; Kieran F Scott
Journal:  J Biol Chem       Date:  2013-03-12       Impact factor: 5.157

8.  Relationship between membrane physical properties and secretory phospholipase A2 hydrolysis kinetics in S49 cells during ionophore-induced apoptosis.

Authors:  Rachel W Bailey; Erin D Olson; Mai P Vu; Taylor J Brueseke; Leslie Robertson; Ryan E Christensen; Kristen H Parker; Allan M Judd; John D Bell
Journal:  Biophys J       Date:  2007-06-01       Impact factor: 4.033

9.  Characterization of a human coagulation factor Xa-binding site on Viperidae snake venom phospholipases A2 by affinity binding studies and molecular bioinformatics.

Authors:  Grazyna Faure; Veerabasappa T Gowda; Rachid C Maroun
Journal:  BMC Struct Biol       Date:  2007-12-06

10.  A Lipidomic Perspective of the Action of Group IIA Secreted Phospholipase A2 on Human Monocytes: Lipid Droplet Biogenesis and Activation of Cytosolic Phospholipase A2α.

Authors:  Juan P Rodríguez; Elbio Leiguez; Carlos Guijas; Bruno Lomonte; José M Gutiérrez; Catarina Teixeira; María A Balboa; Jesús Balsinde
Journal:  Biomolecules       Date:  2020-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.